MOXICA 125 DRY SYRUP contains Amoxycillin which belongs to the group of medicines called Penicillin. MOXICA 125 DRY SYRUP is used to treat infections in pediatric patients caused by bacteria that affects different parts of the body.
It is also used in combination with other medicines in pediatric patients to treat stomach ulcers.
MOXICA 125 DRY SYRUP is not recommended for use in children allergic to amoxicillin, penicillin, and/or other antibiotics.
Before administering MOXICA 125 DRY SYRUP, inform your doctor if the child has glandular fever (viral infection caused by Epstein Barr Virus), unable to urinate regularly, kidney problems, and/or liver problems (such as hepatic impairment).
MOXICA 125 DRY SYRUP is not recommended for use in pregnant and breastfeeding women since it is used only in children and adolescents (aged below 18 years). It is also not recommended for use in elderly patients.
The most common side effects of taking MOXICA 125 DRY SYRUP are skin rash, nausea and diarrhoea. Consult and inform your doctor before taking the medicine.
Used in paediatric patients:
MOXICA 125 DRY SYRUP works by inhibiting the synthesis of penicillin binding proteins which leads to activation of autolytic enzymes in bacterial cell wall resulting in lysis/destruction of bacterial cell wall thus preventing the spread of infection in affected children.
Administer MOXICA 125 DRY SYRUP in child as advised by your physician. Add water upto the mark on the bottle and shake well. The volume should be adjusted upto the mark by adding more water if necessary. Close the bottle tightly and shake the mixture well. Your doctor will decide the exact dose and duration of treatment for your child depending on child’s age, body weight and disease condition.
Stop administering MOXICA 125 DRY SYRUP and consult and inform your doctor immediately in case your child experiences:
Nausea/vomiting:
Have the child take this medicine with or just after a meal or a snack. Let the child stick to simple meals and avoid having rich or spicy food.
Diarrhoea:
Ask the child to drink lots of fluids such as water or fruit juices so that the child is sufficiently hydrated. Do not administer any medicine to treat the condition. Consult your doctor if the symptom does not improve.
MOXICA 125 DRY SYRUP is not recommended for use in pregnant women as it is used only in children.
MOXICA 125 DRY SYRUP is not recommended for use in breastfeeding women as it is used only in children.
MOXICA 125 DRY SYRUP should be taken with caution in children with kidney problems. Consult and inform your doctor before taking the medicine.
MOXICA 125 DRY SYRUP should be taken with caution in children with liver problems such as hepatic impairment. Consult and inform your doctor before taking the medicine.
Do not administer MOXICA 125 DRY SYRUP if the child is allergic to Amoxicillin, other penicillin or antibiotics, and/or any of the other ingredients of this medicine.
Before taking MOXICA 125 DRY SYRUP inform your doctor if the child:
Use in Paediatrics:
MOXICA 125 DRY SYRUP is recommended for use in children and adolescents (below 18 years of age). Consult and inform your doctor before taking the medicine.
Use in Geriatrics:
MOXICA 125 DRY SYRUP is not recommended for use in elderly patients as it is used only in children.
A. Drug-Drug interactions:
Before taking MOXICA 125 DRY SYRUP, inform your doctor if the child is on any of the following medicine:
Overdosage:
If the child or anyone else accidentally take too much of MOXICA 125 DRY SYRUP, Consult and inform your doctor immediately or visit the nearby hospital. Symptoms of overdose are stomach upset (associated with signs such as nausea/vomiting/diarrhoea), and/or crystals in the urine (associated with signs such as cloudy urine, difficulty while urinating).
Drug | : | Amoxicillin |
Pharmacological Category | : | Penicillin |
Therapeutic Indication | : | Bacterial Infection, Stomach ulcer when used in combination with other medicines |
Dosage Forms | : | Tablet, Dispersible Tablet, Capsule, Chewable tablet, Oral Suspension, Suspension, Oral Drops, Syrup, Dry Syrup, Injection |
What MOXICA 125 DRY SYRUP is used for?
MOXICA 125 DRY SYRUP is used in pediatric patients to treat bacterial infections affecting different parts of the body which is also used in combination with other medicines to treat stomach ulcers.
How MOXICA 125 DRY SYRUP works?
MOXICA 125 DRY SYRUP works by inhibiting the synthesis of penicillin binding proteins which leads to activation of autolytic enzymes in bacterial cell wall resulting in lysis/destruction of bacterial cell wall thus preventing the spread of infection in affected children.
Can MOXICA 125 DRY SYRUP stain teeth?
Yes, MOXICA 125 DRY SYRUP may stain the teeth which may occur very rarely in children. Good oral hygiene practices like brushing teeth may help to prevent it. Consult and inform your doctor if the symptom persists.
What are side effects of MOXICA 125 DRY SYRUP?
The most common side effects of taking MOXICA 125 DRY SYRUP are skin rash, nausea, and/or diarrhoea. These symptoms will subside after treatment. Consult and inform your doctor any of these symptoms worsens in child.
How MOXICA 125 DRY SYRUP is taken?
Administer MOXICA 125 DRY SYRUP in child as advised by your physician. Add water upto the mark on the bottle and shake well. Adjust the volume upto the mark by adding more water if necessary. Close the bottle tightly and shake the mixture well. Your doctor will decide the exact dose and duration of treatment for your child depending on child’s age, body weight and disease condition.
1. K.D.Tripathi. Beta- Lactam Antibiotics. Essentials of medical pharmacology. Seventh edition. 2013. Page - 723.
2. Bobak J. Akhavan; Niloufar R. Khanna; Praveen Vijhani. Amoxicillin. NIH National Library of Medicine. National Center for Biotechnology Information. StatPearls [Internet]. August 2021. [Accessed on 11th October 2022] https://www.ncbi.nlm.nih.gov/books/NBK482250/
3. Raúl J. Andrade and Paul M. Tulkens. Hepatic safety of antibiotics used in primary care. NIH National Library of Medicine. National Center for Biotechnology Information. PMC PubMed Central. July 2011. [Accessed on 11th October 2022] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3112029/
4. Athlone Laboratories Limited. Health Products Regulatory Authority (HPRA). [Revised in March 2022] [Accessed on 11th October 2022] http://www.hpra.ie/img/uploaded/swedocuments/8fec8da4-af2e-4a8c-b2c6-70e950b43422.pdf
Written By Dr. K .AZEEM HUSSAIN, B.D.S
Last updated on 12 Oct 2022 | 04:21 PM(IST)
The contents of this website are for informational purposes only and not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition. Do not disregard professional medical advice or delay in seeking it because of something you have read on this website.